NCT06371092

Brief Summary

The main objective of this study is to evaluate if the use of UltraEZ during at-home bleaching treatment is effective in reducing tooth sensitivity, as well as doesn't affect the degree of tooth bleaching.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Jan 2023

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2023

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

22 days

First QC Date

April 8, 2024

Last Update Submit

April 16, 2024

Conditions

Keywords

Tooth bleachingVital bleachingDesensitizing agentsTooth sensitivity

Outcome Measures

Primary Outcomes (1)

  • Questionnaire of dental sensitivity

    Patients should answer a dental sensitivity questionnaire. A a 5-point subjective numerical classification scale will be used (0=no sensitivity, 1=light, 2=mild, 3=considerable and 4=severe). Patients will a score of 0 during the treatment will be defined as patients with no sensitivity. The individual highest recorded score will be the grade of intensity for each patient.

    Daily, during 3 weeks

Secondary Outcomes (1)

  • Shade evaluation with a dental spectrophotometer

    Once a week, during 3 weeks

Study Arms (2)

UltraEZ Group

EXPERIMENTAL

Patients put in their bleaching trays the UltraEZ desensitizing gel for 30 minutes before the bleaching treatment every day during three weeks.

Drug: UltraEZ

Placebo Group

PLACEBO COMPARATOR

Patients put in their bleaching trays the UltraEZ placebo gel for 30 minutes before the bleaching treatment every day during three weeks.

Drug: Placebo

Interventions

General examination with bite-wings. Dental prophylaxis (dental scaling and polishing with an abrasive paste). Alginate impressions of both arches. Creation of individualized bleaching trays and a position-finder tray of both arches. Application of the UltraEZ gel in the bleaching trays for 30 minutes. Application of the bleaching gel in the bleaching trays during 6-8 hours

UltraEZ Group

General examination with bite-wings. Dental prophylaxis (dental scaling and polishing with an abrasive paste). Alginate impressions of both arches. Creation of individualized bleaching trays and a position-finder tray of both arches. Application of the placebo gel in the bleaching trays for 30 minutes. Application of the bleaching gel in the bleaching trays during 6-8 hours

Placebo Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • No oral or systemic pathology
  • Periodontally healthy
  • No cavities
  • Tooth shade of the upper and lower canines A2 or darker

You may not qualify if:

  • Adhesive restorations or prostheses in the anterior region
  • Enamel or dentin alterations
  • Smoking
  • Pregnant women
  • Undergone prior bleaching treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Medicine and Dentistry

Santiago de Compostela, A Coruña, 15705, Spain

Location

MeSH Terms

Conditions

Dentin Sensitivity

Interventions

UltraEZ

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized, triple-blind clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 8, 2024

First Posted

April 17, 2024

Study Start

January 31, 2023

Primary Completion

February 22, 2023

Study Completion

March 1, 2023

Last Updated

April 17, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations